Develop a patient engagement plan to support the launch of Product X and optimize PRMA outcomes via the incorporation of the patient voice

Client Challenge

Our client was preparing for regulatory and subsequent HTA submissions.

To prepare for launch, they wished to investigate the potential to engage with patient advocacy groups / patient organisations with the specific aim of leveraging their input during HTAs to:​

  • Speed up payer assessments ​
  • Accelerate patient access and/or​ Drive optimal P&R outcomes.

P4A Solution

Identify markets where the patient voice can influence HTA decisions either formally or informally, and the associated mechanism / pathway for patient input in the process.

  • Identify and screen patient organisations and advocacy groups for interest ​
  • Create a country-specific engagement plan to facilitate patient/organization involvement.​
  • Develop educational materials to support the engagement plan, introducing the client and product

The Successful Outcome​

Prioritized engagement with patient organizations for maximum HTA impact​.

Tailored engagement plan outlining activities and advice to optimize influence from patient organizations while enabling the company to focus resources where they would have most impact.

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

Explore other case studies

P4A Services

For all access and Rare Disease related overview enquiries